What Happened? A number of stocks fell in the afternoon session after the "AI replacement" narrative reached a fever pitch ...

Veeva Systems Inc. VEEV is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The ...

Ideally, a business will show two trends; firstly a growing return on capital employed (ROCE) and secondly, an increasing amount of capital employed. If you see this, it typically means it's a company ...

Emerging biotechs and top biopharmas trust Link to power customer engagement and provide structured datasets to fuel AI initiatives ...

Veeva Systems (NYSE: VEEV) today announced Veeva eSource, a new Veeva SiteVault application designed to significantly reduce ...

Veeva Systems has announced Veeva eSource, a new Veeva SiteVault application designed to streamline the flow of clinical ...

Veeva Systems Inc. VEEV is well-poised for growth in the coming quarters, courtesy of its strong product portfolio. The optimism, led by a solid fourth-quarter fiscal 2025 performance and strategic ...

Veeva Systems has outperformed peers with strong momentum and a Q1 beat, but its valuation remains stretched at 13x revenue and 37x P/E. Despite robust fundamentals—market share opportunity, vendor ...

Detailed price information for Veeva Systems Inc (VEEV-N) from The Globe and Mail including charting and trades.

If you are wondering whether Veeva Systems at around US$209.98 is a fair price, a premium, or an opportunity, this article is ...

Veeva reported better-than-expected sales and earnings in August. The stock's valuation ratios tumbled, while it lagged major indexes over the past year. Veeva's valuation suddenly looks cheap when ...

Veeva Systems delivered strong Q2 results, with robust revenue growth and a fortress-like balance sheet, reinforcing its leadership in the biopharma sector. The company resolved its legal dispute with ...